Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury
Peixiang Lan, … , Xiang Xiao, Xian Chang Li
Peixiang Lan, … , Xiang Xiao, Xian Chang Li
Published April 24, 2017
Citation Information: J Clin Invest. 2017;127(6):2222-2234. https://doi.org/10.1172/JCI91075.
View: Text | PDF
Research Article Immunology Inflammation

TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury

  • Text
  • PDF
Abstract

Tissue-resident immune cells play a key role in local and systemic immune responses. The liver, in particular, hosts a large number of invariant natural killer T (iNKT) cells, which are involved in diverse immune responses. However, the mechanisms that regulate survival and homeostasis of liver iNKT cells are poorly defined. Here we have found that liver iNKT cells constitutively express the costimulatory TNF superfamily receptor OX40 and that OX40 stimulation results in massive pyroptotic death of iNKT cells, characterized by the release of potent proinflammatory cytokines that induce liver injury. This OX40/NKT pyroptosis pathway also plays a key role in concanavalin A–induced murine hepatitis. Mechanistically, we demonstrated that liver iNKT cells express high levels of caspase 1 and that OX40 stimulation activates caspase 1 via TNF receptor–associated factor 6–mediated recruitment of the paracaspase MALT1. We also found that activation of caspase 1 in iNKT cells results in processing of pro–IL-1β to mature IL-1β as well as cleavage of the pyroptotic protein gasdermin D, which generates a membrane pore–forming fragment to produce pyroptotic cell death. Thus, our study has identified OX40 as a death receptor for iNKT cells and uncovered a molecular mechanism of pyroptotic cell death. These findings may have important clinical implications in the development of OX40-directed therapies.

Authors

Peixiang Lan, Yihui Fan, Yue Zhao, Xiaohua Lou, Howard P. Monsour, Xiaolong Zhang, Yongwon Choi, Yaling Dou, Naoto Ishii, Rafik M. Ghobrial, Xiang Xiao, Xian Chang Li

×

Figure 4

Requirement of TRAF6 in OX40-mediated activation of caspase 1.

Options: View larger image (or click on image) Download as PowerPoint
Requirement of TRAF6 in OX40-mediated activation of caspase 1.
(A) FACS-...
(A) FACS-sorted iNKT cells from WT B6 and Cd4-Cre Traf6fl/fl mice were stimulated with OX86 for 30 minutes, and caspase 1 activation was determined by immunoblotting. β-Actin was used as a loading control. Data shown represent one of 6 individual experiments. (B) FACS-sorted iNKT cells from WT B6 and Cd4-Cre Traf6fl/fl mice were stimulated with OX86 for 24 hours, and the induction of active caspase 1 in iNKT cells was determined using a specific staining Ab recognizing cleaved caspase 1 and assessed by FACS. The plot shown represents one of 6 experiments. (C) WT B6 mice and Cd4-Cre Traf6fl/fl mice were treated with OX86 or a control IgG (200 μg, i.p.), and iNKT cells in liver were analyzed by FACS 2 weeks later. The FACS plot shown represents one of 6 independent experiments. (D) The summary graphs represent relative percentage and absolute number of iNKT cells in WT B6 and TRAF6-deleted mice with or without OX86 treatment, as described in C. Data shown are mean ± SD of 6 mice in each group. (E) ELISA analysis of IL-1β and IL-18 levels in the serum of WT B6 and Cd4-Cre Traf6fl/fl mice treated with control IgG or OX86 (200 μg, i.p.). Data represent mean ± SD of 6 mice in each group. The P value was calculated by unpaired 2-tailed Student’s t test between control IgG and OX86 treatment (D and E), *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts